Leading the future of Bio-Medicine

LMNTIC Biotech revolutionizes biology and precision medicine using our magnetic manipulation technology

LMNTIC Biotech leads the way in precise high-throughput cell manipulation. All this made possible by our unique patented technology that allows us to move cells along magnetic circuits.

In the rise of precision medicine and AI augmented health, cells are still being analyzed as a group average. We need a better and more accessible solutions for single cell isolation.

Revolutionize your experience with
our cutting-edge technology

LMNTIC Biotech leads the way in precise high-throughput cell manipulation. All this made possible by our unique patented technology that allows us to precisely move cells along a magnetic circuit.

PRECISE

Our platform ensures the next level of precision: Our results are more than 99.9% pure. Each isolated cell takes one chamber.

SIMPLE

Our enrichment procedures require minimal sample prep and hands on time. The hands-off nature allows for maximum reproducibility.

AFFORDABLE

L:Cell Platform is based on re-usable, easily swappable chips that are affordable to produce.

EVERY CELL IS
UNIQUE.

The future with
LMNTIC

The next generation of cellular research requires data on a single-cell resolution.
Our technologies provide the key to a cheaper, simpler, and more precise future.

Media

PRESS
RELEASES

MediHub and LMNTIC Biotech Sign MOU to Strengthen Industrial Competitiveness

15 April 2024

Through this business agreement, MediHub Co., Ltd. and LMNtique Biotech Co., Ltd. have decided to establish an advisory panel consisting of professional medical personnel. This panel will focus…

PRESS
RELEASES

Seoul Bio Hub holds ‘Swiss Networking Day’

17 October 2023

This event, attended by about 50 people, included an announcement of the companies finally selected for the ‘Seoul-Basel Startup Hub Acceleration Program’ (hereinafter referred to as the Basel Program)…
PRESS
RELEASES

The four major ISTs competed over start-ups… This year's UNIST hosted IST joint startup competition

3 November 2022

The ‘2022 Korea Institute of Science and Technology Joint Startup Contest’, co-hosted by four science and technology institutes including UNIST, KAIST, DGIST, and GIST, concluded its two-day schedule at the Lahan Hotel in Ulsan…

PRESS
RELEASES

Expectations for growth as a ‘global unicorn company’ through commercialization of new materials and devices

5 October 2022

The Magnetism-Based Life Care Research Center at DGIST is creating new industries in Korea in various fields using electromagnetic materials and device source patents held by participating researchers….

PRESS
RELEASES

LMNTIC Biotech, Accelerating the Commercialization of Cell Control and Diagnostic Platforms

13 September 2022

There is a place that is transforming the paradigm of precision medicine by developing a new cell precision control and diagnostic platform…..

PRESS
RELEASES

DGIST Student startup, selected for TIPS by the SMB-Venture Department

21 July 2022

Daegu Gyeongbuk Institute of Technology (DGIST) announced on the 21st that LMNTIC Biotech…..